LINC01287 and hepatocellular carcinoma: Virtually, knockdown of LINC01287 upregulates E-cadherin level and reduces N-cadherin and Vimentin levels in hepatocellular carcinoma cells, indicating that LINC01287 is also involved in the EMT of hepatocellular carcinoma [10].